US Patent 7595397 Compounds which modulate the CB2 receptor
Patent 7595397 was granted and assigned to Boehringer Ingelheim on September, 2009 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 8, 2006
0
Date of Patent
September 29, 2009
0
Patent Application Number
11608537
0
Patent Inventor Names
Eugene Richard Hickey
0
David S. Thomson
0
Doris Riether
0
Renee Zindell
0
Innocent Mushi
0
Monika Ermann
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7595397 Compounds which modulate the CB2 receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.